Mice that model severe dystroglycanopathy due to forebrain deletion of Dag1 or Pomt2, which is required for Dystroglycan glycosylation, show significant impairment of CCK+/CB1R+ IN development. The gene discussed is CCK; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.